Late life depression

Late-life depression refers to a major depressive episode occurring for the first time in an older person (usually over 50 or 60 years of age). The term can also include depression that develops in an older person who suffered from the illness earlier in life.[1] Concurrent medical problems and lower functional expectations of elderly patients often obscure the degree of impairment. Typically, elderly patients with depression do not report depressed mood, but instead present with less specific symptoms such as insomnia, anorexia, and fatigue. Elderly persons sometimes dismiss less severe depression as an acceptable response to life stress or a normal part of aging.[2][3][4][5][6][7]

Primary care is most often where diagnosis and treatment of late-life depression occurs, though is often missed or not treated even following a diagnosis.[8] Diagnosis is made in the same way as other age groups, using DSM-5 criteria for major depressive disorder;however, diagnosis can be more difficult due to the unique challenges the elderly face.[9][8] Common reasons for this difficulty include: medical illnesses and medication side effects that present similarly to depression, difficulty communicating with providers, lack of time in an appointment, and beliefs about mental illness and treatment from the patient, friends, family members, and society.[8][10] Treatments for late-life depression include medicine and psychotherapy, along with lifestyle changes such as exercise, bright light therapy, and family support[8] In patients who do not respond to initial treatments, neurostimulation techniques such as electroconvulsive therapy (ECT) can be used.[9] ECT has demonstrated effectiveness in treating the elderly.[11]

Symptoms and diagnosis

Diagnosis of depression in late life is made using the same criteria for Major Depressive Disorder found in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5)

To meet criteria for a major depressive episode, a patient must have five of the nine symptoms listed below nearly every day for at least two weeks and must have at least either a depressed mood or anhedonia.[12][13] The symptoms they are facing must also harm their ability to function in daily life and must not be better explained by a medical illness or a substance.[13] To further meet criteria for Major Depressive Disorder, the depressive episode must not be attributable to another psychiatric disorder such as psychosis or a bipolar disorder.[13]

  1. Depressed or sad mood
  2. Anhedonia (loss of interest in pleasurable activities)
  3. Sleep disturbance (increased or decreased sleep)
  4. Appetite disturbance (increased or decreased appetite) typically with weight change
  5. Energy disturbance (increased or decreased energy/activity level), usually fatigue
  6. Poor memory or concentration
  7. Feelings of guilt or worthlessness
  8. Psychomotor retardation or agitation (a change in mental and physical speed perceived by other people)
  9. Thoughts of wishing they were dead; suicidal ideation or suicide attempts

Causes

The exact changes in brain chemistry and function that cause either late-life or earlier onset depression are unknown. It is known, however, that brain changes can be triggered by the stresses of certain life events such as illness, childbirth, death of a loved one, life transitions (such as retirement), interpersonal conflicts, or social isolation. Risk factors for depression in elderly persons include a history of depression, chronic medical illness, female sex, being single or divorced, brain disease, alcohol use disorder, use of certain medications, and stressful life events.

Treatments

Treatment is effective in about 80% of identified cases, when treatment is provided. Effective management requires a biopsychosocial approach, combining pharmacotherapy and psychotherapy. Therapy generally results in improved quality of life, enhanced functional capacity, possible improvement in medical health status, increased longevity, and lower health care costs. Improvement should be evident as early as two weeks after the start of therapy, but full therapeutic effects may require several months of treatment. Therapy for older patients should be continued for longer periods than are typically used in younger patients.[14][15]

Psychotherapy

Psychologic therapies are recommended for elderly patients with depression because of this group's vulnerability to adverse effects and high rates of medical problems and medication use. Psychotherapeutic approaches include cognitive behavioral therapy, supportive psychotherapy, problem-solving therapy, and interpersonal therapy.[16] Life review therapy is another type of therapy with evidence supporting its usefulness in older adults with moderate depression.[17] The potential benefit of psychotherapy is not diminished by increasing age. Older adults often have better treatment compliance, lower dropout rates, and more positive responses to psychotherapy than younger patients.[16] While therapy can be beneficial, it is not always provided due to factors such as lack of trained therapists or lack of coverage by health insurance.[18]

Pharmacotherapy

Pharmacotherapy for acute episodes of depression usually is effective and free of complications. Antidepressant medications are often the first treatment choice for adults with moderate or severe depression, sometimes along with psychotherapy. The most promising therapeutic effect is achieved when the treatment continues for at least six weeks.[19] Underuse or misuse of antidepressants and prescribing inadequate dosages are the most common mistakes physicians make when treating elderly patients for depression. Only 10% to 40% of depressed elderly patients are given medication.

Selective serotonin reuptake inhibitors, commonly referred to as SSRIs, are considered first line pharmacotherapy for depression in late life as they are more tolerable and safer than other antidepressants.[20] Serotonin-norepinephrine reuptake inhibitors (SNRIs) are considered second-line but also can be useful for patients suffering from chronic pain.[21][22] Atypical antidepressants such as bupropion and mirtazapine have not been studied extensively in older adults but appear to offer some benefit.[23][24] Monoamine oxidase inhibitors (MAOIs) similarly have been shown to offer some benefit, but have not been studied extensively[25] MAOIs must be used with caution to prevent side effects such as serotonin syndrome and adrenergic crisis.[26]

Tricyclic antidepressants are no longer the first line therapy for depression, but can still benefit patients who do not respond to initial therapies.[22] TCAs have also demonstrated a unique ability to prevent re-occurrence of depression following electroconvulsive therapy.[27][28][29] TCAs are typically not used initially due to their side effects and risk from overdose compared to SSRIs.[30][31] A TCA overdose can be fatal at a much lower dose than SSRIs.[31]

Antidepressants, in general, may also work by playing a neuroprotective role in how they relieve anxiety and depression. It's thought that antidepressants may increase the effects of brain receptors that help nerve cells keep sensitivity to glutamate which is an organic compound of a nonessential amino acid. This increased support of nerve cells lowers glutamate sensitivity, providing protection against the glutamate overwhelming and exciting key brain areas related to depression. Although antidepressants may not cure depression, they can lead to remission, which is the disappearance or nearly complete reduction of depression symptoms.[32][33][34]

Continuation and maintenance treatments for depression in older people

A 2016 Cochrane review provided limited evidence that continuing antidepressant medication for one year seems to reduce the risk of depression recurrence with no additional harm.[35] However, a robust recommendation can not be drawn about psychological treatments or combination treatments in preventing recurrence.  

Neurostimulation

Neurostimulation, specifically electroconvulsive therapy (ECT) is an effective treatment for depression in the elderly. It is particularly useful in treating severe major depression that does not respond well to the above treatments.[36] In the geriatric population specifically, including patients over the age of 85, ECT provides a safe and effective treatment option.[37][38] Compared to treatment with younger patients, ECT appears to work more effectively in the older patients.[39] A typical course of ECT treatment ranges from 6 to 12 treatments, with some requiring more or less.[40] A normal treatment schedule in the United States might include three treatments a week on Monday, Wednesday, and Friday. Two treatments a week compares favorably with three and can also be used.[41] Maintenance ECT, which is ECT given longitudinally after the initial set of acute treatments, also helps depression in late life and helps prevent reoccurring depression.[42]

If an older person requires hospitalization for their depression, ECT has been shown in multiple studies to work faster than medicine and reduce mortality associated with depression.[43][44] Even in cases such as depression following a stroke, ECT can be efficacious; however, the evidence is not as strong on its ability to treat vascular depression caused by long-term disease, versus an acute event like a stroke.[45][46]

Transcranial magnetic stimulation (TMS) is another example of neurostimulation used to treat depression, but ECT is considered to be the more effective modality.[47][48][49]

Epidemiology

Major depression is a mental disorder characterized by an all-encompassing low mood accompanied by low self-esteem, and loss of interest or pleasure in normally enjoyable activities. Nearly five million of the 31 million Americans who are 65 years or older are clinically depressed, and one million have major depression. Approximately 3% of healthy elderly persons living in the community have major depression. Recurrence may be as high as 40%. Suicide rates are nearly twice as high in depressed patients as in the general population. Major depression is more common in medically ill patients who are older than 70 years and hospitalized or institutionalized. Severe or chronic diseases associated with high rates of depression include stroke (30–60%), coronary heart disease (8–44%), cancer (1–40%), Parkinson's disease (40%), Alzheimer's disease (20–40%), and dementia (17–31%).[50]

Minor depression is a clinically significant depressive disorder that does not fulfill the duration criterion or the number of symptoms necessary for the diagnosis of major depression. Minor depression, which is more common than major depression in elderly patients, may follow a major depressive episode. It also can be a reaction to routine stressors in older populations. 15–50% of patients with minor depression develop major depression within two years.[51]

Research

Brain imaging (functional/structural MRI) may help direct the search for microscopic abnormalities in brain structure and function responsible for late life depression. Ultimately, imaging technologies may serve as tools for early diagnosis and subtyping of depression.[52]

See also

References

  1. ↑ Taylor WD (September 2014). "Clinical practice. Depression in the elderly". The New England Journal of Medicine. 371 (13): 1228–36. doi:10.1056/NEJMcp1402180. PMID 25251617.
  2. ↑ Alexopoulos GS, Kelly RE (October 2009). "Research advances in geriatric depression". World Psychiatry. 8 (3): 140–9. doi:10.1002/j.2051-5545.2009.tb00234.x. PMC 2755271. PMID 19812743.
  3. ↑ Steffens DC, Potter GG (February 2008). "Geriatric depression and cognitive impairment". Psychological Medicine. 38 (2): 163–75. doi:10.1017/S003329170700102X. PMID 17588275. S2CID 36713188.
  4. ↑ Mitchell AJ, Subramaniam H (September 2005). "Prognosis of depression in old age compared to middle age: a systematic review of comparative studies". The American Journal of Psychiatry. 162 (9): 1588–601. doi:10.1176/appi.ajp.162.9.1588. PMID 16135616.
  5. ↑ Yohannes AM, Baldwin RC (2008). "Medical Comorbidities in Late-Life Depression". Psychiatric Times. 25 (14).
  6. ↑ Krishnan KR (January 2007). "Concept of disease in geriatric psychiatry". The American Journal of Geriatric Psychiatry. 15 (1): 1–11. doi:10.1097/01.JGP.0000224600.37387.4b. PMID 17095750.
  7. ↑ Alexopoulos GS (2005). "Depression in the elderly". Lancet. 365 (9475): 1961–70. doi:10.1016/S0140-6736(05)66665-2. PMID 15936426. S2CID 34666321.
  8. 1 2 3 4 "UpToDate". www.uptodate.com. Retrieved 20 November 2019.
  9. 1 2 "UpToDate". www.uptodate.com. Retrieved 20 November 2019.
  10. ↑ Sirey JA, Bruce ML, Alexopoulos GS, Perlick DA, Raue P, Friedman SJ, Meyers BS (March 2001). "Perceived stigma as a predictor of treatment discontinuation in young and older outpatients with depression". The American Journal of Psychiatry. 158 (3): 479–81. doi:10.1176/appi.ajp.158.3.479. PMID 11229992.
  11. ↑ van der Wurff FB, Stek ML, Hoogendijk WJ, Beekman AT (October 2003). "The efficacy and safety of ECT in depressed older adults: a literature review". International Journal of Geriatric Psychiatry. 18 (10): 894–904. doi:10.1002/gps.944. PMID 14533122. S2CID 20799377.
  12. ↑ Birrer RB, Vemuri SP (May 2004). "Depression in later life: a diagnostic and therapeutic challenge". American Family Physician. 69 (10): 2375–82. PMID 15168957.
  13. 1 2 3 American Psychiatric Association (22 May 2013). Diagnostic and Statistical Manual of Mental Disorders (Fifth ed.). American Psychiatric Association. CiteSeerX 10.1.1.988.5627. doi:10.1176/appi.books.9780890425596. ISBN 978-0-89042-555-8.
  14. ↑ Frazer CJ, Christensen H, Griffiths KM (June 2005). "Effectiveness of treatments for depression in older people". The Medical Journal of Australia. 182 (12): 627–32. doi:10.5694/j.1326-5377.2005.tb06849.x. PMID 15963019. S2CID 18342952.
  15. ↑ Smith GS, Alexopoulos GS (August 2009). "Neuroimaging in geriatric psychiatry". International Journal of Geriatric Psychiatry. 24 (8): 783–7. doi:10.1002/gps.2335. PMC 5675131. PMID 19593778.
  16. 1 2 Alexopoulos GS, Raue PJ, Kanellopoulos D, Mackin S, Arean PA (August 2008). "Problem solving therapy for the depression-executive dysfunction syndrome of late life". International Journal of Geriatric Psychiatry. 23 (8): 782–8. doi:10.1002/gps.1988. PMID 18213605. S2CID 35390619.
  17. ↑ Korte J, Bohlmeijer ET, Cappeliez P, Smit F, Westerhof GJ (June 2012). "Life review therapy for older adults with moderate depressive symptomatology: a pragmatic randomized controlled trial". Psychological Medicine. 42 (6): 1163–73. doi:10.1017/S0033291711002042. PMID 21995889. S2CID 38756731.
  18. ↑ "UpToDate". www.uptodate.com. Retrieved 4 December 2019.
  19. ↑ Wilson K, Mottram P, Sivanranthan A, Nightingale A (2001). "Antidepressant versus placebo for depressed elderly". The Cochrane Database of Systematic Reviews (2): CD000561. doi:10.1002/14651858.CD000561. PMC 7066642. PMID 11405969.
  20. ↑ Solai LK, Mulsant BH, Pollock BG (2001). "Selective serotonin reuptake inhibitors for late-life depression: a comparative review". Drugs & Aging. 18 (5): 355–68. doi:10.2165/00002512-200118050-00006. PMID 11392444. S2CID 23519411.
  21. ↑ Nelson JC, Wohlreich MM, Mallinckrodt CH, Detke MJ, Watkin JG, Kennedy JS (March 2005). "Duloxetine for the treatment of major depressive disorder in older patients". The American Journal of Geriatric Psychiatry. 13 (3): 227–35. doi:10.1176/appi.ajgp.13.3.227. PMID 15728754.
  22. 1 2 "UpToDate". www.uptodate.com. Retrieved 4 December 2019.
  23. ↑ Steffens DC, Doraiswamy PM, McQuoid DR (September 2001). "Bupropion SR in the naturalistic treatment of elderly patients with major depression". International Journal of Geriatric Psychiatry. 16 (9): 862–5. doi:10.1002/gps.424. PMID 11571765. S2CID 26398542.
  24. ↑ Anttila SA, Leinonen EV (2001). "A review of the pharmacological and clinical profile of mirtazapine". CNS Drug Reviews. 7 (3): 249–64. doi:10.1111/j.1527-3458.2001.tb00198.x. PMC 6494141. PMID 11607047.
  25. ↑ Georgotas A, McCue RE, Hapworth W, Friedman E, Kim OM, Welkowitz J, et al. (October 1986). "Comparative efficacy and safety of MAOIs versus TCAs in treating depression in the elderly". Biological Psychiatry. 21 (12): 1155–66. doi:10.1016/0006-3223(86)90222-2. PMID 3756264. S2CID 44627288.
  26. ↑ "UpToDate". www.uptodate.com. Retrieved 4 December 2019.
  27. ↑ Flint AJ, Rifat SL (January 1998). "The treatment of psychotic depression in later life: a comparison of pharmacotherapy and ECT". International Journal of Geriatric Psychiatry. 13 (1): 23–8. doi:10.1002/(SICI)1099-1166(199801)13:1<23::AID-GPS725>3.0.CO;2-J. PMID 9489577.
  28. ↑ Sackeim HA, Haskett RF, Mulsant BH, Thase ME, Mann JJ, Pettinati HM, et al. (March 2001). "Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial". JAMA. 285 (10): 1299–307. doi:10.1001/jama.285.10.1299. PMID 11255384.
  29. ↑ Mittmann N, Herrmann N, Shulman KI, Silver IL, Busto UE, Borden EK, et al. (October 1999). "The effectiveness of antidepressants in elderly depressed outpatients: a prospective case series study". The Journal of Clinical Psychiatry. 60 (10): 690–7. doi:10.4088/jcp.v60n1008. PMID 10549686.
  30. ↑ Anderson IM, Ferrier IN, Baldwin RC, Cowen PJ, Howard L, Lewis G, et al. (June 2008). "Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines". Journal of Psychopharmacology. 22 (4): 343–96. doi:10.1177/0269881107088441. PMID 18413657. S2CID 25658129.
  31. 1 2 Nelson J (May 2017). "Tricyclic and Tetracyclic Drugs". The American Psychiatric Association Publishing Textbook of Psychopharmacology. American Psychiatric Association Publishing. doi:10.1176/appi.books.9781615371624.as09. ISBN 978-1-58562-523-9.
  32. ↑ Taylor WD, Kuchibhatla M, Payne ME, Macfall JR, Sheline YI, Krishnan KR, Doraiswamy PM (September 2008). "Frontal white matter anisotropy and antidepressant remission in late-life depression". PLOS ONE. 3 (9): e3267. Bibcode:2008PLoSO...3.3267T. doi:10.1371/journal.pone.0003267. PMC 2533397. PMID 18813343.
  33. ↑ Murphy GM, Kremer C, Rodrigues HE, Schatzberg AF (October 2003). "Pharmacogenetics of antidepressant medication intolerance". The American Journal of Psychiatry. 160 (10): 1830–5. doi:10.1176/appi.ajp.160.10.1830. PMID 14514498.
  34. ↑ Serafeim A, Holder MJ, Grafton G, Chamba A, Drayson MT, Luong QT, et al. (April 2003). "Selective serotonin reuptake inhibitors directly signal for apoptosis in biopsy-like Burkitt lymphoma cells". Blood. 101 (8): 3212–9. doi:10.1182/blood-2002-07-2044. PMID 12515726.
  35. ↑ Wilkinson P, Izmeth Z (September 2016). "Continuation and maintenance treatments for depression in older people". The Cochrane Database of Systematic Reviews. 9: CD006727. doi:10.1002/14651858.cd006727.pub3. PMC 6457610. PMID 27609183.
  36. ↑ Pagnin D, de Queiroz V, Pini S, Cassano GB (March 2004). "Efficacy of ECT in depression: a meta-analytic review". The Journal of ECT. 20 (1): 13–20. doi:10.1097/00124509-200403000-00004. PMID 15087991. S2CID 25843283.
  37. ↑ Kerner N, Prudic J (February 2014). "Current electroconvulsive therapy practice and research in the geriatric population". Neuropsychiatry. 4 (1): 33–54. doi:10.2217/npy.14.3. PMC 4000084. PMID 24778709.
  38. ↑ Geduldig ET, Kellner CH (April 2016). "Electroconvulsive Therapy in the Elderly: New Findings in Geriatric Depression". Current Psychiatry Reports. 18 (4): 40. doi:10.1007/s11920-016-0674-5. PMID 26909702. S2CID 44569093.
  39. ↑ Rhebergen D, Huisman A, Bouckaert F, Kho K, Kok R, Sienaert P, et al. (March 2015). "Older age is associated with rapid remission of depression after electroconvulsive therapy: a latent class growth analysis". The American Journal of Geriatric Psychiatry. 23 (3): 274–82. doi:10.1016/j.jagp.2014.05.002. PMID 24951182.
  40. ↑ "UpToDate". www.uptodate.com. Retrieved 27 November 2019.
  41. ↑ Kellner CH (2012). Brain Stimulation in Psychiatry. Cambridge: Cambridge University Press. doi:10.1017/cbo9780511736216. ISBN 978-0-511-73621-6.
  42. ↑ van Schaik AM, Comijs HC, Sonnenberg CM, Beekman AT, Sienaert P, Stek ML (January 2012). "Efficacy and safety of continuation and maintenance electroconvulsive therapy in depressed elderly patients: a systematic review". The American Journal of Geriatric Psychiatry. 20 (1): 5–17. doi:10.1097/JGP.0b013e31820dcbf9. PMID 22183009.
  43. ↑ Philibert RA, Richards L, Lynch CF, Winokur G (September 1995). "Effect of ECT on mortality and clinical outcome in geriatric unipolar depression". The Journal of Clinical Psychiatry. 56 (9): 390–4. PMID 7665536.
  44. ↑ Spaans HP, Sienaert P, Bouckaert F, van den Berg JF, Verwijk E, Kho KH, Stek ML, Kok RM (January 2015). "Speed of remission in elderly patients with depression: electroconvulsive therapy v. medication". The British Journal of Psychiatry. 206 (1): 67–71. doi:10.1192/bjp.bp.114.148213. PMID 25323140.
  45. ↑ Kales HC, Maixner DF, Mellow AM (February 2005). "Cerebrovascular disease and late-life depression". The American Journal of Geriatric Psychiatry. 13 (2): 88–98. doi:10.1176/appi.ajgp.13.2.88. PMID 15703317.
  46. ↑ Currier MB, Murray GB, Welch CC (1992). "Electroconvulsive therapy for post-stroke depressed geriatric patients". The Journal of Neuropsychiatry and Clinical Neurosciences. 4 (2): 140–4. doi:10.1176/jnp.4.2.140. PMID 1627974.
  47. ↑ Berlim MT, Van den Eynde F, Daskalakis ZJ (July 2013). "Efficacy and acceptability of high frequency repetitive transcranial magnetic stimulation (rTMS) versus electroconvulsive therapy (ECT) for major depression: a systematic review and meta-analysis of randomized trials". Depression and Anxiety. 30 (7): 614–23. doi:10.1002/da.22060. PMID 23349112. S2CID 2173645.
  48. ↑ Slotema CW, Blom JD, Hoek HW, Sommer IE (July 2010). "Should we expand the toolbox of psychiatric treatment methods to include Repetitive Transcranial Magnetic Stimulation (rTMS)? A meta-analysis of the efficacy of rTMS in psychiatric disorders". The Journal of Clinical Psychiatry. 71 (7): 873–84. doi:10.4088/JCP.08m04872gre. PMID 20361902.
  49. ↑ "Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression: A Systematic Review and Meta-Analysis of Randomized Controlled Trials". Ontario Health Technology Assessment Series. 16 (5): 1–66. 2016. PMC 4808719. PMID 27099642.
  50. ↑ American Psychiatric Association 2000a, p. 354
  51. ↑ Rapaport MH, Judd LL, Schettler PJ, Yonkers KA, Thase ME, Kupfer DJ, et al. (April 2002). "A descriptive analysis of minor depression". The American Journal of Psychiatry. 159 (4): 637–43. doi:10.1176/appi.ajp.159.4.637. PMID 11925303.
  52. ↑ Soares JC, Mann JJ (January 1997). "The anatomy of mood disorders--review of structural neuroimaging studies". Biological Psychiatry. 41 (1): 86–106. doi:10.1016/S0006-3223(96)00006-6. PMID 8988799. S2CID 32444863.
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.